Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 3/20 | 0.61 |
| ▸ | SELL | P14151 | 1/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | SIGLEC7 | Q9Y286 | 7/20 | 0.49 |
| ▸ | MAG | P20916 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CD22 | P20273 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8664558 | 0.93 | NANP (0.64) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL3746151 | 0.93 | NANP (0.61) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL2190269 | 0.91 | NANP (0.59) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL16416308 | 0.91 | NANP (0.59) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL10699657 | 0.91 | NANP (0.52) | NANPMAGL3MBTL1CD22 | |
| SCHEMBL12506343 | 0.91 | NANP (0.52) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL3808166 | 0.90 | NANP (0.58) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL2742889 | 0.90 | NANP (0.74) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL8489507 | 0.90 | NANP (0.74) | NANPSELLSELPSIGLEC7MAG | |
| SCHEMBL13125452 | 0.90 | NANP (0.74) | NANPSELLSELPSIGLEC7MAG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250257347-A1 | COAGULATION FACTOR X ACTIVATING ENZYME AND USE THEREOF | Beijing Solobio Genetechnology Co., Ltd. (CN) | 2025-08-14 | — | — | US | claimed |
| EP-4509601-A1 | COAGULATION FACTOR X ACTIVATING ENZYME AND USE THEREOF | Jiangsu BioJeTay Biotechnology Co., Ltd. (CN) | 2025-02-19 | — | — | EP | claimed |
| WO-2023198171-A1 | COAGULATION FACTOR X ACTIVATING ENZYME AND USE THEREOF | 北京三诺佳邑生物技术有限责任公司 | 2023-10-19 | — | — | WO | claimed |
| EP-2183261-A1 | POLYSIALIC ACID DERIVATIVES, METHODS OF PRODUCTION, AND USES IN ENHANCING CANCER ANTIGEN PRODUCTION AND TARGETING | Children's Hospital & Research Center at Oakland (US) | 2010-05-12 | — | — | EP | claimed |
| CN-100523188-C | Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof | INST GENETICS LLC (US) | 2009-08-05 | — | — | CN | claimed |
| WO-2009006613-A1 | POLYSIALIC ACID DERIVATIVES, METHODS OF PRODUCTION, AND USES IN ENHANCING CANCER ANTIGEN PRODUCTION AND TARGETING | CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND (US) | 2009-01-08 | — | — | WO | claimed |
| EP-1083181-B1 | Process for the preparation of O-acetyl sialic acid specific immunoglobulin and method of quantification thereof as a biomarker for acute lymphoblastic leukaemia | COUNCIL SCIENT IND RES (IN) | 2008-11-26 | — | — | EP | claimed |
| CN-1553955-A | Platlet glycoprotein IB alpha fusion polypeptides and methods of use thereof | �Ŵ�ѧԺ�������ι�˾ | 2004-12-08 | — | — | CN | claimed |
| US-6693177-B1 | MULTIPLE CHROMATOGRAPHIC SEPARATIONS, NEUTRALIZATION AND DIALYSIS | MANDAL CHITRA (IN) | 2004-02-17 | — | — | US | claimed |
| EP-1083181-A1 | Process for the preparation of O-acetyl sialic acid specific immunoglobulin and method of quantification thereof | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2001-03-14 | — | — | EP | claimed |
| EP-0328420-A2 | Gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology | The Biomembrane Institute (US) | 1989-08-16 | — | — | EP | claimed |
| EP-4742902-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742901-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742900-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| WO-1996040169-A1 | BACTERIAL INHIBITION WITH AN OLIGOSACCHARIDE COMPOUND | NEOSE TECHNOLOGIES, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996017614-A1 | ADJUVANT-INCORPORATED CELLULAR ANTIGENS: CONJUGATION AND METHODS | JOHN WAYNE CANCER INSTITUTE (US) | 1996-06-13 | — | — | WO | disclosed |
| US-5272138-A | Naturally occurring gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology | THE BIOMEMBRANE INSTITUTE (US) | 1993-12-21 | — | — | US | disclosed |
| US-5075218-A | Screening for antibodies which bind carbohydrate epitopes of tumor-associated antigens, and uses thereof | BIOMIRA, INC. (CA) | 1991-12-24 | — | — | US | disclosed |
| EP-0328420-A2 | Gangliosides containing de-N-acetyl-sialic acid and their applications as modifiers of cell physiology | The Biomembrane Institute (US) | 1989-08-16 | — | — | EP | disclosed |